Introduction
Carcinoebmryonic antigen (CEA) is mostly used to detect early recurrences after surgery in patients with colorectal cancer [1] . In this report, we present a case in which paroxetine use caused increase in CEA. In literature, a similar case has not been previously presented.
Case
A 61-year-old male patient, married, with a child, suffered two depressive episodes, with the first one occurring 15 years ago and the second one 7.5 years ago. After the second episode, he received paroxetine treatment for a year, but 6 months after the cessation of treatment, a third depressive episode occurred, and paroxetine was started again at 20 mg/day. After a response was obtained, he continued to use 10 mg/day. Six years after the last episode, in routine controls, CEA levels began to increase. did not reveal cancer. Therefore, in this patient, the increase in CEA was attributed to paroxetine, and the treatment was discontinued. A month later, CEA level became 17.
Discussion
CEA increase during paroxetine use may be related to the increase in serotonin, serotonin−carcinoid syndrome relationship, or the effect on laboratory methods, and the cause is not known yet [2, 3] . During the evaluation of cases with increased CEA levels, paroxetine use should be investigated.
